Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9453)
All Articles published online
|
Publishing Process of This Article
|
Jul 15, 2018 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lote H, Valeri N, Chau I. HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer. World J Gastrointest Oncol 2018; 10(7): 159-171 [PMID: 30079142 DOI: 10.4251/wjgo.v10.i7.159] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v10/i7/159.htm |
| Number | Citing Articles |
| 1 |
Yin-Hong Yan, Xiao-Yi Lei, Wei-Ping Hu. Comparative effectiveness and tolerability of targeted agents combined with chemotherapy in patients with HER2-positive gastroesophageal cancer. Saudi Journal of Gastroenterology 2022; 28(3): 175 doi: 10.4103/sjg.sjg_367_21
|
| 2 |
Hazel Lote, Ian Chau. Emerging HER2-directed therapeutic agents for gastric cancer in early phase clinical trials. Expert Opinion on Investigational Drugs 2022; 31(1): 59 doi: 10.1080/13543784.2022.2030311
|
| 3 |
Katharina Huber, Thomas Kunzke, Achim Buck, Rupert Langer, Birgit Luber, Annette Feuchtinger, Axel Walch. Multimodal analysis of formalin-fixed and paraffin-embedded tissue by MALDI imaging and fluorescence in situ hybridization for combined genetic and metabolic analysis. Laboratory Investigation 2019; 99(10): 1535 doi: 10.1038/s41374-019-0268-z
|
| 4 |
Seyed Samad Hosseini, Saeed Khalili, Behzad Baradaran, Negar Bidar, Mohammad-Ali Shahbazi, Jafar Mosafer, Mahmoud Hashemzaei, Ahad Mokhtarzadeh, Michael R. Hamblin. Bispecific monoclonal antibodies for targeted immunotherapy of solid tumors: Recent advances and clinical trials. International Journal of Biological Macromolecules 2021; 167: 1030 doi: 10.1016/j.ijbiomac.2020.11.058
|
| 5 |
Li Zhang, Virginia Aragon‐Sanabria, Anusha Aditya, Marcello Marelli, Tianye Cao, Feng Chen, Barney Yoo, Kai Ma, Li Zhuang, Thais Cailleau, Luke Masterson, Melik Z. Turker, Rachel Lee, Gabriel DeLeon, Sebastien Monette, Raffaele Colombo, Ronald J. Christie, Pat Zanzonico, Ulrich Wiesner, J. Anand Subramony, Michelle S. Bradbury. Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with “Hit and Run” Tumor Delivery to Eradicate Gastric Cancer. Advanced Therapeutics 2023; 6(3) doi: 10.1002/adtp.202200209
|
| 6 |
Masahiro Yasunaga. Antibody therapeutics and immunoregulation in cancer and autoimmune disease. Seminars in Cancer Biology 2020; 64: 1 doi: 10.1016/j.semcancer.2019.06.001
|
| 7 |
Mingyuan Li, Siyu Ma, Xiangyang Xie, Nan Liu, Zhiping Li, Zhenbo Yang, Guangyu Gao, Shiqin Li, Yuan Li, Shuangshuang Li, Xingguo Mei, Hui Zhang. Vincristine-doxorubicin co-loaded artificial low-density lipoproteins towards solid tumours. European Journal of Medicinal Chemistry 2021; 226: 113802 doi: 10.1016/j.ejmech.2021.113802
|
| 8 |
Jovana R Gotovac, David SH Liu, Michael J Yates, Julia V Milne, Arthi A Macpherson, Kaylene J Simpson, Guy D Eslick, Catherine Mitchell, Cuong P Duong, Wayne A Phillips, Nicholas J Clemons. GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinoma. The Journal of Pathology 2020; 252(3): 317 doi: 10.1002/path.5528
|
| 9 |
Yu-Ge Zhu, Bu-Fan Xiao, Jing-Tao Zhang, Xin-Run Cui, Zhe-Ming Lu, Nan Wu. Genetically Modified T Cells for Esophageal Cancer Therapy: A Promising Clinical Application. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.763806
|